Injector Apparatus and Method for Drug Delivery
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2011/046812, filed Aug 5, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,861,521 | Injector Apparatus and Method for Drug Delivery In force · High confidence | Forsight VISION4, Inc. | In force | High confidence | ||
| US 10,265,215 | Injector Apparatus and Method for Drug Delivery In force · High confidence | Forsight VISION4, Inc. | In force | High confidence | ||
| US 9,033,911 | Injector Apparatus and Method for Drug Delivery In force · High confidence | Forsight VISION4, Inc. | In force | High confidence | ||
| US 8,905,963 | Injector Apparatus and Method for Drug Delivery In force · High confidence | Forsight VISION4, Inc. | In force | High confidence | ||
| US 11,786,396 | Injector Apparatus and Method for Drug Delivery In force · High confidence | Forsight VISION4, Inc. | In force | High confidence | ||
| Application 18/470,282 | Injector Apparatus and Method for Drug Delivery Abandoned Abandoned May 3, 2024 | ForSight Vision4, Inc. | Abandoned | Abandoned May 3, 2024 | ||
| Application 18/652,633 | Injector Apparatus and Method for Drug Delivery Pending Not granted | ForSight Vision4, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Forsight VISION4, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.